miltefosine has been researched along with Granulocytic Leukemia in 2 studies
miltefosine: hexadecyl phosphocholine derivative of cisplatin; did not substantially activate HIV long terminal repeat; less toxic than cisplatin
miltefosine : A phospholipid that is the hexadecyl monoester of phosphocholine.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beckers, T | 2 |
| Voegeli, R | 1 |
| Hilgard, P | 1 |
| Klenner, T | 1 |
| Nooter, K | 1 |
| Holtmann, H | 1 |
2 other studies available for miltefosine and Granulocytic Leukemia
| Article | Year |
|---|---|
Molecular and cellular effects of hexadecylphosphocholine (Miltefosine) in human myeloid leukaemic cell lines.
Topics: Antineoplastic Agents; Cell Differentiation; Cell Division; Colony-Forming Units Assay; Dose-Respons | 1994 |
Influence of hexadecylphosphocholine (miltefosine) on cytokine synthesis and biological responses.
Topics: Animals; Antineoplastic Agents; Blotting, Northern; Colony-Forming Units Assay; Concanavalin A; Cyto | 1996 |